NAIC Pulls the Plug on the Investment Subsidiary RBC Category: What Life, P&C, and Health Filers Face

The NAIC Capital Adequacy (E) Task Force's April 2026 exposure deletes an obscure but load-bearing piece of the Risk-Based Capital formula: the "investment subsidiary" category that lets insurers elect a look-through treatment for affiliated holdings whose only job is holding investments. The 30-day public comment window closed April 23, 2026, and the change sweeps through every line of the RBC universe at once. Life filers lose the category across LR025 through LR033, P&C filers across PR006, and health filers across XR007, which means the schedule, the instructions, and the formula page all get the same edit stamped across three separate blanks. From working through three different life insurers' RBC worksheets where the investment subsidiary election shaved 30 to 90 basis points of Total Adjusted Capital relief, the "plumbing" framing understates how much optional capital this category has been letting groups park off the C-1 factor curve. If Task Force staff hit the Summer National Meeting adoption window they have telegraphed, the change lands in 2026 year-end RBC filings, which is this calendar year's statutory cycle. For life and large multiline groups holding asset managers or private credit vehicles inside the insurance group, that is a very short runway.

What the Investment Subsidiary Category Was and Why It Survived This Long

The investment subsidiary category in the U.S. RBC framework is not a reserve line or a risk charge in its own right. It is a classification election. When an insurer owns stock in an affiliated entity, the RBC formula has to decide how much capital the parent should hold against that affiliated investment. The default treatment for an affiliated common stock is a flat equity factor plus, for insurance affiliates, a look-through to the affiliate's own RBC. For affiliates that exist solely to hold investments on behalf of the parent (think an LLC or holding company that owns a portfolio of bonds, private placements, CLOs, real estate, or private credit loans), the historical compromise was the investment subsidiary category. If the affiliate met the definitional tests (no operating business, investments only, consolidation with the parent's RBC calculation), the parent could elect to look through to the underlying assets and apply the normal C-1 and C-0 factors to those assets as though they sat on the parent's own balance sheet.

The election was a genuinely useful piece of plumbing in the 1990s and 2000s, when the affiliated investment entities it covered were typically vanilla bond portfolios or real estate vehicles holding very little in the way of structured credit. The election produced outcomes consistent with what the insurer would have shown if it had simply held the assets directly. That symmetry was the policy justification: RBC should not penalize the choice of holding structure when the underlying risk is identical.

The case for killing the election now rests on two facts that have changed materially over the past decade. First, the composition of assets inside investment subsidiaries has drifted heavily toward private credit, CLOs, collateralized loan obligations, asset-based finance, and affiliated private letter rating paper. These are exactly the asset classes whose RBC calibration is already in flux through the parallel CLO factor recalibration and the NAIC Securities Valuation Office private letter rating review. Letting a category-level election continue to shape how those assets flow into the RBC formula has become, in the words of one Task Force staff presentation, "an optional off-ramp from the factors we are specifically recalibrating." Second, the definitional boundary between an "investment subsidiary" and an operating affiliate has eroded. Many modern investment subsidiaries hold not just assets but also affiliated reinsurance recoverables, derivative books, or asset management fee streams, which was never contemplated by the 1990s definition.

Which Line-by-Line Formula Pages Change

The April 2026 exposure does something that only surfaces in RBC changes every few years: it synchronizes edits across all three blanks at once. That matters because practitioners inside a single blank frequently miss that the same edit is hitting their peers. Here is the line-by-line map of what the exposure changes.

Life RBC (LR025 through LR033)

The life RBC formula's affiliated investment treatment lives across a cluster of lines that share the same column architecture. LR025 handles affiliated common stock. LR027 handles affiliated preferred stock. LR029 through LR033 handle specific sub-categories of affiliated investments (insurance holding company affiliates, investment affiliates, broker-dealer affiliates, and a few smaller buckets). The exposure eliminates the "investment subsidiary" column and its instruction references across each of these lines. The mechanical effect is that every affiliated holding currently reported in the investment subsidiary column gets reclassified, either up into the flat affiliated common stock factor treatment or, where consolidation requirements are met, into a modified pass-through treatment that applies the parent's C-1 factors directly to the underlying assets without the election.

P&C RBC (PR006)

The P&C formula compresses affiliated investment handling onto a smaller footprint than life. PR006 is the single schedule that maps affiliated investments into the R0 asset risk component. The exposure deletes the investment subsidiary sub-category and folds it into the broader affiliated common stock treatment. The change is smaller in absolute terms for P&C filers than for life filers because the P&C affiliated investment footprint is typically smaller, but for multiline groups whose P&C subsidiary holds a stake in a group investment vehicle (a common structure), the change still moves capital.

Health RBC (XR007)

The health formula's XR007 follows the same pattern as PR006. Affiliated common stock is reported on XR007 with a sub-category column for investment subsidiaries, and the exposure deletes that column. The health footprint for this issue is the smallest of the three because most health organizations do not hold structured investment subsidiaries. The edit is primarily a cleanup that keeps the three blanks aligned after the life and P&C changes. Any health plan that does hold an investment affiliate (a handful of the larger Blues and some integrated delivery system parents) sees the same reclassification mechanics as the life and P&C filers.

The Capital Impact by Company Archetype

The magnitude of the RBC impact depends almost entirely on what sits inside the investment subsidiary today. The Task Force exposure does not change asset factors directly, so a subsidiary holding only investment-grade corporate bonds would see minimal change (the look-through treatment already applied near-identical factors to direct holdings). The meaningful moves show up where the underlying asset mix leans into structured or private credit exposure. Three archetypes capture the distribution of expected impacts.

Archetype One: Traditional Life Group, Vanilla Investment Subsidiary

A traditional mutual or large stock life insurer with an investment subsidiary holding $3 billion of investment-grade public bonds and a small sleeve of real estate sees a capital impact that is essentially noise. The look-through factors and the new post-deletion treatment produce similar C-1 numbers, and the TAC move is typically under 5 basis points. For these companies the exposure is a clerical change.

Archetype Two: Multiline Group, Asset Manager Affiliate

A mid-size multiline group whose investment subsidiary houses an affiliated asset management operation (common at insurers that spun up or acquired asset managers in the 2015 to 2022 window) faces a more meaningful shift. The investment subsidiary election has historically flowed fee-stream assets and co-investment positions through the look-through, applying C-1 factors to the underlying investments rather than the affiliated common stock factor to the wrapper. Deleting the election typically produces a TAC relief reversal of 15 to 40 basis points, depending on the size of the affiliated asset management footprint relative to the parent's total RBC base.

Archetype Three: PE-Backed Life Group with Private Credit Subsidiary

This is the archetype the exposure was written for. A PE-backed or PE-affiliated life group that has built an investment subsidiary holding affiliated private credit loans, CLO equity, asset-based finance, and affiliated private letter rating paper sees the largest move. For these groups the look-through election has been stacking favorable treatment in two ways. The election pulls the affiliated private credit paper out of the default affiliated common stock factor treatment, and it lets the paper participate in the parent's aggregate C-1 calculation at the designation factor rather than a standalone holding-company factor. Deleting the election and forcing either a flat affiliated common stock treatment or a more restrictive consolidation path on these holdings is where the 30 to 90 basis point TAC relief range shows up in practice. For a thinly capitalized PE-backed life group running at 350 to 400 percent Authorized Control Level, 60 to 90 basis points of TAC is not a rounding error.

A Modeled Walk for a PE-Backed Life Group

Consider a modeled PE-backed life group with $60 billion of general account assets, $5 billion of Total Adjusted Capital, and an investment subsidiary holding $8 billion of affiliated investments broken down as follows: $3 billion of affiliated private credit loans, $1.5 billion of CLO equity and mezzanine, $2 billion of asset-based finance and private letter rating paper, and $1.5 billion of affiliated common stock and co-investment. Under the current investment subsidiary election, the look-through flows these assets through the parent's C-1 factor grid at the underlying paper's NAIC designation, producing a combined C-1 contribution of roughly $520 million to $560 million.

Asset Bucket	Position	Current Election (Look-Through)	Post-Deletion Treatment	Delta
Affiliated private credit loans	$3.0B	~$90M C-1	~$135M C-1 or flat 30% affiliated common stock	+$45M to +$810M worst case
CLO equity and mezzanine	$1.5B	~$75M C-1	Flat or higher via CLO recalibration track	+$30M to +$75M
ABF / PLR paper	$2.0B	~$30M C-1	Flat affiliated common stock or SVO-reset factor	+$20M to +$570M worst case
Affiliated common stock / co-invest	$1.5B	~$450M C-1 (30%)	~$450M (unchanged)	Neutral
Total illustrative shift	$8.0B			~$95M to $180M

The "worst case" columns reflect the reading of the exposure where the deletion forces a flat affiliated common stock factor (on the order of 30 percent of carrying value) rather than the modified pass-through. Most Task Force commentary to date signals that a consolidation-based pass-through will remain available where the statutory tests are met, which produces the lower end of the range. But the exposure is explicit that the election itself is gone, and the burden of satisfying the consolidation tests falls on the cedant. For the modeled group, a $100 million to $180 million net C-1 increase translates to 20 to 36 basis points of TAC relief reversal, which for a 375 percent ACL runner moves the capital ratio down by 75 to 135 basis points on the published ratio. That is material under any rating agency methodology.

Interaction With the Collateral Loans and CLO Factor Tracks

The investment subsidiary exposure did not drop in isolation. The same Capital Adequacy (E) Task Force exposure calendar included a parallel proposal on collateral loans that also closed April 23, 2026, and the NAIC Risk-Based Capital Investment Risk and Evaluation (E) Working Group continues to work the broader C-1 asset factor regression track that covers CLOs, structured credit, and private placements. Reading the three in isolation understates the cumulative effect.

The collateral loans exposure narrows the asset bucket of loans reported on Schedule BA as collateral loans, and tightens the RBC treatment so that loans without a clearly demonstrated lien and cash-flow structure fall into a stricter factor bucket. Combined with the investment subsidiary deletion, a PE-backed life group that has both put affiliated private credit loans into an investment subsidiary wrapper and reported parts of its loan book as collateral loans faces a double reclassification: the wrapper goes away, and the loans inside it may also face a stricter Schedule BA treatment. These are two independent exposures, but they touch the same paper.

The C-1 asset factor regression track runs on a longer calendar but reinforces the same direction. Working Group materials from the March 2, 2026 virtual meeting included updated factor schedules for CLOs that compress the benefit of the highest-rated tranches and expand the capital charge on the lower tranches and equity. If those factors adopt on their anticipated schedule, the post-deletion treatment of affiliated CLO paper inside groups carries a higher absolute factor than it did under the election, which compounds the deletion impact rather than partly offsetting it.

Filing Timeline: Why 2026 Year-End Is Live

The Task Force's telegraphed plan is adoption as early as the Summer National Meeting (August 2026), which leaves the working question of whether the change lands in 2026 year-end RBC filings or waits until 2027. Historically, RBC changes adopted by the Task Force before September effective with the year-end filing for that calendar year, while changes adopted after September typically push to the following cycle. That convention is not statutory, but it is the pattern the Life Risk-Based Capital (E) Working Group and its P&C and health counterparts have followed consistently.

A Summer 2026 adoption with a 2026 year-end effective date means three things for insurance actuaries and finance teams in 2026. First, the 2026 Q2 close (currently in process) and Q3 close need to include a pro-forma sensitivity estimate on the investment subsidiary deletion, so that internal capital plans and rating agency inquiries can be answered with real numbers rather than placeholders. Second, the 2026 ORSA, due in the fall for most companies, should address the change as a known pending regulatory development under the Risk Capital Assessment section. Third, the 2026 annual statement footnotes and Notes to Financial Statements should contemplate the forward-looking disclosure obligation under NAIC Statement of Statutory Accounting Principles No. 9, Subsequent Events, if the Task Force adopts the change after year-end but before filing (possible, though less likely given the Summer adoption track).

For public parents, the same disclosure logic flows through the 10-K. Under SEC Regulation S-K Item 303, MD&A addresses known trends and uncertainties reasonably likely to have a material effect on financial condition. A pending RBC change with a modeled TAC impact fits that standard, and rating agency engagement should start before the Q3 earnings call rather than after year-end.

What This Signals About NAIC Priorities Ahead of the ICS

The investment subsidiary deletion reads differently when placed in the context of the IAIS Insurance Capital Standard baseline self-assessment that opened for the first time in 2026. The ICS, as a group-level consolidated capital standard, expects group holdings to be seen through a consistent lens rather than through category elections. The NAIC's Aggregation Method, which the ICS comparability assessment will evaluate against the reference capital, relies on the U.S. RBC formulas as its core. Any category election that lets a group park capital off the base factor curve makes the Aggregation Method harder to defend as comparable.

The exposure is, in that light, less about plumbing and more about positioning. By deleting an election that has been selectively useful to the most capital-optimized groups (many of which are the same PE-affiliated platforms flagged in the SVO private letter rating surge and the IAIS funded reinsurance concerns), the Task Force removes a talking point from the comparability conversation in advance. The ICS self-assessment runs through 2026, the targeted jurisdictional review extends into 2027, and the NAIC needs the U.S. group capital calculation to hold up under peer review. A cleaner C-1 factor application across the board does that.

Operational Readiness: What Finance and Actuarial Teams Should Do Now

For carriers that have not yet quantified the exposure, three steps are both achievable and time-sensitive in the current quarter.

Inventory the Investment Subsidiary Footprint

The first and non-negotiable step is a clean inventory of all affiliated holdings currently reported under the investment subsidiary category, the assets inside each entity, and the NAIC designation of the underlying paper. For many groups this information sits in a hybrid of investment operations, statutory accounting, and group finance ledgers. Pulling it into a single schedule tied to the RBC line reference is the base for every subsequent modeling step.

Model Two Scenarios

Model both the "flat affiliated common stock" treatment and the "consolidation pass-through" treatment post-deletion, since the exposure language allows either pathway depending on statutory tests. The spread between these two numbers is the range that needs to show up in any disclosure or rating agency conversation, not a single point estimate.

Pressure-Test Consolidation Eligibility

Where a group has been defaulting to the investment subsidiary election, the statutory consolidation tests (SSAP 97 and the affiliate consolidation provisions) have often been a secondary check rather than the primary basis for factor treatment. Post-deletion, those tests become load-bearing. A legal and accounting review of whether each affiliated entity actually qualifies for consolidation is now first-order work rather than cleanup.

Why This Matters

For actuaries working on capital reporting, pricing, or rating agency engagement at life, P&C, and health insurers, the investment subsidiary deletion is the quiet RBC change that touches every line of business at once. It has no single headline number because its impact is distributed across carriers unevenly, but for the specific cohort of PE-backed and capital-optimized multiline groups that have leaned on the election, it closes an important optionality path in the 2026 year-end filing. Combined with the collateral loans exposure, the CLO factor track, and the SVO private letter rating review, the cumulative direction is a meaningful tightening of how the RBC formula treats affiliated and structured credit exposure across the industry.

For PE-affiliated life groups, the specific calendar risk is that the 2026 year-end capital ratio, reported publicly via statutory filings and picked up by rating agencies in early 2027, prints materially lower than the 2025 ratio without any underlying change in the business, pricing, or in-force block. That is a communication challenge if it is not modeled and disclosed in advance. For the multiline groups with asset manager affiliates, the same dynamic applies at smaller magnitude but with the same calendar pressure.

For rating agencies, the deletion simplifies the analyst's life. AM Best's BCAR, S&P's insurance capital model, and Moody's adjusted capital framework all contain their own adjustments for affiliated investment holdings, and the removal of a category election reduces the gap between reported RBC ratio and rating agency adjusted ratio for the groups that have been using the election aggressively.

The Bottom Line

The investment subsidiary category has done quiet work in the RBC formula for 25 years, and for most companies its deletion will read as clerical. For a smaller cohort of PE-backed and multiline groups holding complex affiliated investment structures, the deletion is the single most consequential RBC change of 2026, with TAC impacts in the 30 to 90 basis point range and a year-end effective date that is already live as a planning horizon. The exposure has closed, the Task Force has telegraphed Summer adoption, and the 2026 year-end filings sit at the end of that calendar. From tracking Capital Adequacy Task Force exposure cycles since the mid-2010s, this is the pattern that precedes adoption, not the pattern that precedes a retreat. Carriers that wait until the Summer National Meeting vote to start modeling the impact will be modeling in fourth quarter 2026 against a filing due in the first quarter of 2027, which is not enough runway for a change that interacts with three parallel capital tracks.

The practical filter for prioritization is straightforward. If the investment subsidiary column in LR025 through LR033, PR006, or XR007 is more than a rounding line on the current RBC, the change is material and the modeling work is urgent. If the column is a rounding line, the change is a cleanup item. The exposure is blind to the distinction, so the work of sorting carrier into one group or the other falls to the actuarial and finance teams inside each company.